Tolerance of Concurrent Adjuvant Radiation Therapy and Pembrolizumab for Triple Negative Breast Cancer: Real Life Experience-Reference-Cited by-同舟云学术

Tolerance of Concurrent Adjuvant Radiation Therapy and Pembrolizumab for Triple Negative Breast Cancer: Real Life Experience

Published:2024-03 Issue:3 Volume:9 Page:101384
ISSN:2452-1094
Container-title:Advances in Radiation Oncology
language:en
Short-container-title:Advances in Radiation Oncology

Author:

Tison Thais,Loap Pierre,Arnaud Emilie,Cao Kim,Bringer Solene,Kissel Manon,Maaradji Safia,Mainguene Juliette,Pierga Jean-Yves,Lerebours Florence,Vincent-Salomon Anne,Mirabelle Mariana,Bidard Francois-Clement,Loirat Delphine,Kirova Youlia M.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference24 articles.

1. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sørlie;Proc Natl Acad Sci U S A,2001

2. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens;Gubin;Nature,2014

3. Anti-PD-1 and anti-CTLA-4 therapies in cancer: Mechanisms of action, efficacy, and limitations;Seidel;Front Oncol,2018

4. Variation in the incidence and magnitude of tumor-infiltrating lymphocytes in breast cancer subtypes: A systematic review;Stanton;JAMA Oncol,2016

5. PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas;Cimino-Mathews;Hum Pathol,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scleroderma-like Lesions in a Patient Undergoing Combined Pembrolizumab and Routine Chemotherapy: A Case Report and Literature Review;Medicina;2024-07-03

2. Safety of pembrolizumab with concurrent radiotherapy in early stage breast cancer: preliminary prospective real-world evidence;2024-03-05